World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
91
Citations
50231
World Ranking
1020
National Ranking
553

Medicine

D-Index
91
Citations
50254
World Ranking
11519
National Ranking
5907

Overview

M. Juliana McElrath is affiliated with the University of Washington in the United States and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research encompasses subfields such as Infectious Diseases, Immunology, Virology, Molecular Biology, and Epidemiology.

The areas of research focus prominently include HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, vaccines and immunoinformatics approaches, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and COVID-19 Clinical Research Studies.

Recent publications authored or co-authored by McElrath include:

  • Integrated analysis of multimodal single-cell data (2021, Cell)
  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine (2021, New England Journal of Medicine)
  • mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021, Science)
  • Homologous and Heterologous Covid-19 Booster Vaccinations (2022, New England Journal of Medicine)
  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition (2021, New England Journal of Medicine)

Frequent collaborators in their research include Kristen W. Cohen, Stephen C. De Rosa, Lawrence Corey, Georgia D. Tomaras, and Peter B. Gilbert.

The scientist regularly publishes in several venues, with the most frequent being bioRxiv (Cold Spring Harbor Laboratory), npj Vaccines, Zenodo (CERN European Organization for Nuclear Research), Nature Communications, and PLoS Medicine.

Best Publications

  • Integrated analysis of multimodal single-cell data

    Yuhan Hao;Stephanie Hao;Erica Andersen-Nissen;William M. Mauck

  • MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

    Greg Finak;Andrew McDavid;Masanao Yajima;Jingyuan Deng

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

    Susan P Buchbinder;Devan V Mehrotra;Ann Duerr;Daniel W Fitzgerald

  • HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

    M Juliana McElrath;M Juliana McElrath;Stephen C De Rosa;Stephen C De Rosa;Zoe Moodie;Sheri Dubey

  • Setting the stage: host invasion by HIV.

    Florian Hladik;M. Juliana McElrath;M. Juliana McElrath

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1

    Florian Hladik;Florian Hladik;Polachai Sakchalathorn;Lamar Ballweber;Gretchen Lentz

  • mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.

    Leonidas Stamatatos;Leonidas Stamatatos;Julie Czartoski;Yu Hsin Wan;Leah J. Homad

  • Origin and differentiation of human memory CD8 T cells after vaccination

    Rama Akondy;Mark Fitch;Srilatha Edupuganti;Shu Yang

  • Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.

    Kristen W. Cohen;Susanne L. Linderman;Zoe Moodie;Julie Czartoski

  • HIV-1 Integration Landscape during Latent and Active Infection

    Lillian B. Cohn;Israel T. Silva;Israel T. Silva;Thiago Y. Oliveira;Rafael A. Rosales

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Lawrence Corey;Peter B Gilbert;Michal Juraska;David C Montefiori

  • Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

    Glenda E. Gray;Mary. Allen;Zoe. Moodie;Gavin J. Churchyard

  • A Blueprint for HIV Vaccine Discovery

    Dennis R. Burton;Rafi Ahmed;Rafi Ahmed;Dan H. Barouch;Dan H. Barouch;Dan H. Barouch;Salvatore T. Butera

  • Integrated analysis of multimodal single-cell data

    Yuhan Hao;Stephanie Hao;Erica Andersen-Nissen;William M. Mauck

  • Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination

    M. Juliana McElrath;Barton F. Haynes

  • Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.

    Emilie Seydoux;Leah J. Homad;Anna J. MacCamy;K. Rachael Parks;K. Rachael Parks

  • Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized Clinical Trial

    Iain D. Milligan;Malick M. Gibani;Richard Sewell;Elizabeth A. Clutterbuck

  • Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.

    Amy W. Chung;Amy W. Chung;Manu P. Kumar;Kelly B. Arnold;Wen Han Yu;Wen Han Yu

  • HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1

    Till Schoofs;Florian Klein;Florian Klein;Florian Klein;Malte Braunschweig;Malte Braunschweig;Edward F. Kreider

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Clade B-Based HIV-1 Vaccines Elicit Cross-Clade Cytotoxic T Lymphocyte Reactivities in Uninfected Volunteers

    Guido Ferrari;Will Humphrey;M. Juliana McElrath;Jean–Louis Excler

  • COMPASS identifies T-cell subsets correlated with clinical outcomes

    Lin Lin;Greg Finak;Kevin Ushey;Chetan Seshadri

  • Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

    Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham

  • T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.

    Aude G. Chapuis;Aude G. Chapuis;Daniel N. Egan;Daniel N. Egan;Merav Bar;Merav Bar;Thomas M. Schmitt

Frequent Co-Authors

Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Stephen C. De Rosa
Stephen C. De Rosa Fred Hutchinson Cancer Research Center
Nicole Frahm
Nicole Frahm Fred Hutchinson Cancer Research Center
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
David C. Montefiori
David C. Montefiori Duke University
Michael C. Keefer
Michael C. Keefer University of Rochester
Guido Ferrari
Guido Ferrari Duke University
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology in the USA opens doors to various healthcare careers, many of which benefit from foundational nursing and advanced practice degrees. For those seeking an accessible entry point into nursing, lpn schools easy to get into provide flexible routes to start working in patient care while building essential skills.

As professionals advance, programs such as what is the easiest np program can guide prospective nurse practitioners to degree options that fit demanding schedules and varied academic backgrounds. Especially in mental health fields, specialized programs play a critical role.

For those interested in psychiatric nursing, identifying the best pmhnp programs online ensures quality clinical placements and practical experience, crucial for career success. Moreover, affordability is often a concern, making the cheapest pmhnp programs online an attractive option to advance education without excessive debt.

Choosing the right online degree program linked to Immunology can expand career pathways in healthcare, research, and advanced clinical roles, offering both flexibility and specialized training essential for today’s medical environments.

Best Scientists Citing M. Juliana McElrath

Trending Scientists